Therefore, hyperthermia was combined with the marketed HDAC inhibitors SAHA and LBH589 in gastric cancer cells, and the results showed that the combined application of hyperthermia with SAHA or LBH589 exhibits superior anticancer effects when compared to their respective individual usage. This evidence concerns the gene HDAC9 and gastric cancer.